Jaume Lillo

552 total citations
40 papers, 351 citations indexed

About

Jaume Lillo is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology. According to data from OpenAlex, Jaume Lillo has authored 40 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cellular and Molecular Neuroscience, 19 papers in Pharmacology and 14 papers in Molecular Biology. Recurrent topics in Jaume Lillo's work include Cannabis and Cannabinoid Research (18 papers), Neuroscience and Neuropharmacology Research (17 papers) and Receptor Mechanisms and Signaling (9 papers). Jaume Lillo is often cited by papers focused on Cannabis and Cannabinoid Research (18 papers), Neuroscience and Neuropharmacology Research (17 papers) and Receptor Mechanisms and Signaling (9 papers). Jaume Lillo collaborates with scholars based in Spain, Germany and France. Jaume Lillo's co-authors include Rafael Franco, Gemma Navarro, Rafael Rivas‐Santisteban, Alejandro Lillo, Irene Reyes‐Resina, Eva Martínez‐Pinilla, David Aguinaga, Carlos A. Saura, Ana I. Rodríguez‐Pérez and Ana Muñoz and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of the New York Academy of Sciences and British Journal of Pharmacology.

In The Last Decade

Jaume Lillo

38 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaume Lillo Spain 11 154 134 129 45 34 40 351
Isabel Vieira de Assis Lima Brazil 12 199 1.3× 122 0.9× 188 1.5× 81 1.8× 63 1.9× 18 463
Alejandro Lillo Spain 11 165 1.1× 147 1.1× 204 1.6× 85 1.9× 51 1.5× 27 458
Young Cheul Chung South Korea 8 150 1.0× 53 0.4× 203 1.6× 71 1.6× 49 1.4× 9 357
Pedro Garção Portugal 11 169 1.1× 185 1.4× 157 1.2× 81 1.8× 100 2.9× 14 487
Khalil Eldeeb United States 7 214 1.4× 110 0.8× 220 1.7× 43 1.0× 113 3.3× 17 417
Fabio Carletti Italy 13 233 1.5× 123 0.9× 132 1.0× 31 0.7× 50 1.5× 25 505
Jéssica Ruiz‐Medina Spain 12 171 1.1× 128 1.0× 68 0.5× 59 1.3× 102 3.0× 13 388
Tatiana Bregman Canada 6 84 0.5× 72 0.5× 59 0.5× 65 1.4× 21 0.6× 8 372
Linda Console‐Bram United States 10 247 1.6× 170 1.3× 375 2.9× 24 0.5× 61 1.8× 13 563
C.A. da-Silva Brazil 13 222 1.4× 99 0.7× 66 0.5× 64 1.4× 111 3.3× 15 448

Countries citing papers authored by Jaume Lillo

Since Specialization
Citations

This map shows the geographic impact of Jaume Lillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaume Lillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaume Lillo more than expected).

Fields of papers citing papers by Jaume Lillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaume Lillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaume Lillo. The network helps show where Jaume Lillo may publish in the future.

Co-authorship network of co-authors of Jaume Lillo

This figure shows the co-authorship network connecting the top 25 collaborators of Jaume Lillo. A scholar is included among the top collaborators of Jaume Lillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaume Lillo. Jaume Lillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lillo, Jaume, et al.. (2025). Future Perspectives of NMDAR in CNS Disorders. Molecules. 30(4). 877–877. 1 indexed citations
2.
Reyes‐Resina, Irene, et al.. (2025). The Interplay Between CB2 and NMDA Receptors in Parkinson’s Disease. International Journal of Molecular Sciences. 26(19). 9419–9419.
3.
Lillo, Jaume, et al.. (2025). The Orexin System in Addiction: Neuromodulatory Interactions and Therapeutic Potential. Brain Sciences. 15(10). 1105–1105.
4.
Navarro, Gemma, Jaume Lillo, Carlos A. Saura, et al.. (2025). Cannabinoid CB1 Receptor Activation Mitigates N-Methyl-d-aspartate Receptor-Mediated Neurotoxicity. ACS Pharmacology & Translational Science. 8(9). 3019–3032. 1 indexed citations
5.
Marín, Silvia, Alberto Alvarez‐Iglesias, Jaume Lillo, et al.. (2025). Novel protocol for metabolomics data normalization and biomarker discovery in human tears. Clinical Chemistry and Laboratory Medicine (CCLM). 63(8). 1599–1609. 1 indexed citations
6.
Lillo, Jaume, Christian Griñán‐Ferré, Aina Bellver‐Sanchís, et al.. (2025). Cannabidiol as a multifaceted therapeutic agent: mitigating Alzheimer's disease pathology and enhancing cognitive function. Alzheimer s Research & Therapy. 17(1). 109–109. 2 indexed citations
7.
Rivas‐Santisteban, Rafael, et al.. (2024). GPR88 impairs the signaling of kappa opioid receptors in a heterologous system and in primary striatal neurons. Neuropharmacology. 265. 110242–110242. 1 indexed citations
8.
Franco, Rafael, et al.. (2024). The Olfactory Trail of Neurodegenerative Diseases. Cells. 13(7). 615–615. 11 indexed citations
9.
Torrent, Claudia Llinás del, Ángel González, Jaume Lillo, et al.. (2024). Allosterism in the adenosine A2A and cannabinoid CB2 heteromer. British Journal of Pharmacology. 182(14). 3371–3384. 3 indexed citations
10.
Rivas‐Santisteban, Rafael, Ana Muñoz, Jaume Lillo, et al.. (2024). Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons. npj Parkinson s Disease. 10(1). 220–220. 3 indexed citations
11.
Reyes‐Resina, Irene, et al.. (2024). The Expression and Functionality of CB1R-NMDAR Complexes Are Decreased in A Parkinson’s Disease Model. International Journal of Molecular Sciences. 25(5). 3021–3021. 3 indexed citations
12.
Franco, Rafael, et al.. (2024). Olfactory receptors in neural regeneration in the central nervous system. Neural Regeneration Research. 20(9). 2480–2494. 9 indexed citations
13.
14.
Lillo, Alejandro, et al.. (2023). Gene regulation in activated microglia by adenosine A3 receptor agonists: a transcriptomics study. Purinergic Signalling. 20(3). 237–245. 7 indexed citations
15.
Lillo, Jaume, Gemma Navarro, Rafael Franco, et al.. (2021). Carnitine palmitoyltransferase 1C negatively regulates the endocannabinoid hydrolase ABHD6 in mice, depending on nutritional status. British Journal of Pharmacology. 178(7). 1507–1523. 12 indexed citations
16.
Reyes‐Resina, Irene, Alejandro Lillo, Jaume Lillo, et al.. (2021). Methamphetamine Blocks Adenosine A2A Receptor Activation via Sigma 1 and Cannabinoid CB1 Receptors. International Journal of Molecular Sciences. 22(5). 2743–2743. 1 indexed citations
17.
Rivas‐Santisteban, Rafael, Jaume Lillo, Ana Muñoz, et al.. (2021). Novel Interactions Involving the Mas Receptor Show Potential of the Renin–Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia. Neurotherapeutics. 18(2). 998–1016. 17 indexed citations
18.
Martínez‐Pinilla, Eva, Alberto J. Rico, Rafael Rivas‐Santisteban, et al.. (2020). Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates. Brain Structure and Function. 225(7). 2153–2164. 21 indexed citations
19.
Lillo, Jaume, et al.. (2020). Nr2e3 functional domain ablation by CRISPR-Cas9D10A identifies a new isoform and generates retinitis pigmentosa and enhanced S-cone syndrome models. Neurobiology of Disease. 146. 105122–105122. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabel Vieira de Assis Lima Breakdown of academic impact, for papers by Alejandro Lillo Breakdown of academic impact, for papers by Young Cheul Chung Breakdown of academic impact, for papers by Pedro Garção Breakdown of academic impact, for papers by Khalil Eldeeb Breakdown of academic impact, for papers by Fabio Carletti Breakdown of academic impact, for papers by Jéssica Ruiz‐Medina Breakdown of academic impact, for papers by Tatiana Bregman Breakdown of academic impact, for papers by Linda Console‐Bram Breakdown of academic impact, for papers by C.A. da-Silva
Rankless by CCL
2026